PATLY.AIApplication
17200471 · CYCLIC TETRAMER COMPOUNDS AS PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS
Filed 2021-03-12 · Granted · Patent 11813306 (2023-11-14) The official file ↗The patent and its PDF ↗ · Art unit 1654 · Examiner Jeanette M Lieb Easy · CPC A61K 38/12 · NOVARTIS AG · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
Office actions
1
first was Non-final rejection
RCEs
0
no appeal
To first action
20.2 mo
to disposition 32.1 mo
Statutes raised
DP
1 actions read